n/a

Abstract Title:

β-glucan from barley and its lipid-lowering capacity: a meta-analysis of randomized, controlled trials.

Abstract Source:

Eur J Clin Nutr. 2010 Dec ;64(12):1472-80. Epub 2010 Oct 6. PMID: 20924392

Abstract Author(s):

S S AbuMweis, S Jew, N P Ames

Article Affiliation:

S S AbuMweis

Abstract:

BACKGROUND/OBJECTIVES: To more precisely quantify the effect of barleyβ-glucan on blood lipid concentrations in humans and to examine the factors that could affect its efficacy.

SUBJECTS/METHODS: Eleven eligible randomized clinical trials published from 1989 to 2008 were identified from nine databases. Weighted mean effect sizes were calculated for net differences in lipid profile using a random effect model (RevMan 4.2).

RESULTS: Overall, barley andβ-glucan isolated from barley lowered total and low-density lipoprotein (LDL) cholesterol concentrations by 0.30 mmol/l (95% confidence interval (CI): -0.39 to -0.21, P<0.00001) and 0.27 mmol/l (95% CI: -0.34 to -0.20, P<0.00001), respectively, compared with control. The pattern of cholesterol-lowering action of barley in this analysis could not be viewed as a dose-dependent response. There were no significant subgroup differences by type of intervention and food matrix.

CONCLUSIONS: Increased consumption of barely products should be considered as a dietary approach to reduce LDL cholesterol concentrations.

Study Type : Meta Analysis

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.